Information  X 
Enter a valid email address

Peabody Capital No 2 (41LI)

  Print   

Tuesday 14 April, 2020

Peabody Capital No 2

Response to Covid-19

RNS Number : 4180J
Peabody Capital No 2 PLC
14 April 2020
 

 

Peabody Capital plc/ Peabody Capital No 2 plc

Peabody's response to Covid-19

 

Peabody's business continuity and pandemic response plans were activated on 21 February 2020 to ensure a good level of preparedness. We continue to follow the advice of Government and Public Health England and our frontline teams continue to provide essential services to support people who rely on us

 

During this unprecedented crisis, Peabody's focus has been on three key priorities. 

 

· To protect our teams, residents and the people who benefit from our care and support services;

· To continue providing essential services; and

· To proactively inform, engage and support the most vulnerable in our communities.

 

We entered this period with a strong liquidity position and appropriate control and governance procedures in place. The financial impacts of the current environment, which remain uncertain, are being assessed through detailed monitoring and reporting of cashflows. We have robust measures in place to ensure that systems and payment processes continue with minimal disruption.

 

Our strong financial planning procedures and stress testing mean that we are prepared to manage the impacts and potential impacts and we can continue to deliver on our organisational priorities throughout the covid-19 pandemic and beyond.

 

For more information, contact: Benjamin Blades, Head of External Affairs, Peabody on 07875020950 or [email protected]

 

Further information is also available on our website here: www.peabody.org.uk/about-us/investors

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
UPDILMJTMTJMBRM

a d v e r t i s e m e n t